PMCB Pharmacyte Biotech, Inc.

Fundamentals / CIK 0001157075 / USD

Pharmacyte Biotech, Inc. reported $0 in revenue and a net loss of $16.15M for the trailing twelve months ended July 31, 2026.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open PMCB in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2017 to 2026), reported in USD.

$32.27M$16.13M$0-$20.77MFY 2017 Revenue: $0FY 2017 Net Income: -$4.44M2017FY 2018 Revenue: $0FY 2018 Net Income: -$6.83M2018FY 2019 Revenue: $0FY 2019 Net Income: -$4.07M2019FY 2020 Revenue: $0FY 2020 Net Income: -$3.83M2020FY 2021 Revenue: $0FY 2021 Net Income: -$3.55M2021FY 2022 Revenue: $0FY 2022 Net Income: -$4.24M2022FY 2023 Revenue: $0FY 2023 Net Income: -$4.32M2023FY 2024 Revenue: $0FY 2024 Net Income: $334K2024FY 2025 Revenue: $0FY 2025 Net Income: $30.66M2025FY 2026 Revenue: $0FY 2026 Net Income: -$19.42M2026

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30
Revenue $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Research & Development $391K $438K $407K $469K $691K $916K $301K $460K $2.00M $1.18M
Total Operating Expenses $6.85M $4.38M $8.52M $6.46M $4.39M $3.62M $3.83M $4.10M $6.98M $4.44M
Operating Income -$6.85M -$4.38M -$8.52M -$6.46M -$4.39M -$3.62M -$3.83M -$4.10M -$6.98M -$4.44M
Interest Income $733K $1.42M $3.40M $1.94M $158K $0 -- -- -- --
Interest Expense -- -- -- $0 $509 $3.0K $453 $0 $0 $1.5K
Income Tax Expense $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Net Income -$19.42M $30.66M $334K -$4.32M -$4.24M -$3.55M -$3.83M -$4.07M -$6.83M -$4.44M
Basic EPS -$2.77 $3.19 -$1.80 -$0.22 -$0.27 -$2.45 -$4.23 $0.00 -$0.01 -$0.01
Diluted EPS -$2.77 $3.19 -$1.80 -$0.22 -$0.27 -$2.45 -$4.23 $0.00 -$0.01 -$0.01
Basic Shares Outstanding 8.4M 7.3M 9.6M 19.5M 15.5M 1.4M 903.8K 1.10B 968.6M 845.3M
Diluted Shares Outstanding 8.4M 7.3M 9.6M 19.5M 15.5M 1.4M 903.8K 1.10B 968.6M 845.3M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-07-31 2026-04-30 2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-10-31
Revenue $0 $0 $0 $0 $0 $0 $0 $0
Research & Development $60K $62K $93K $141K $95K $127K $118K $97K
Total Operating Expenses $1.01M $2.51M $2.12M $1.38M $848K $1.04M $960K $1.11M
Operating Income -$1.01M -$2.51M -$2.12M -$1.38M -$848K -$1.04M -$960K -$1.11M
Interest Income $166K $79K $231K $206K $218K $230K $256K $383K
Income Tax Expense $0 -- -- -- $0 -- -- --
Net Income -$5.08M -$4.39M $747K -$7.42M -$8.36M $11.75M -$3.05M -$1.47M
Basic EPS -$0.54 -- -$0.17 -$1.24 -$1.23 -- -$0.44 -$0.39
Diluted EPS -$0.54 -- -$0.17 -$1.24 -$1.23 -- -$0.44 -$0.39
Basic Shares Outstanding 10.7M -- 9.3M 6.8M 6.8M -- 7.0M 7.6M
Diluted Shares Outstanding 10.7M -- 9.3M 6.8M 6.8M -- 7.0M 7.6M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30
Cash & Cash Equivalents $18.60M $15.17M $50.18M $68.04M $85.40M $2.20M $895K $515K $1.06M $3.46M
Short-Term Investments $254K $366K $0 -- -- -- -- -- -- --
Cash & Short-Term Investments $18.86M $15.54M $50.18M $68.04M $85.40M $2.20M $895K $515K $1.06M $3.46M
Total Current Assets $37.42M $22.38M $50.44M $68.15M $85.49M $2.28M $1.04M $653K $1.28M $3.54M
Intangible Assets $0 $1.55M $1.55M $3.55M $3.55M -- -- -- -- --
Other Non-Current Assets $7.7K $7.7K -- -- -- $7.4K $7.4K $7.4K $7.4K $7.4K
Total Non-Current Assets $9.33M $32.79M $9.46M $5.13M $5.13M $5.13M $5.13M $5.13M $5.13M $5.13M
Total Assets $46.75M $55.17M $59.90M $73.28M $90.62M $7.40M $6.17M $5.78M $6.41M $8.67M
Accounts Payable $271K $399K $389K $128K $205K $172K $186K $122K $353K $366K
Total Current Liabilities $826K $2.91M $7.42M $587K $704K $725K $1.03M $743K $644K $580K
Total Non-Current Liabilities $10.95M $363K $12.97M $0 $0 $0 $46K $0 $0 $0
Total Liabilities $11.77M $3.28M $20.39M $587K $704K $725K $1.08M $743K $644K $580K
Common Stock $2.6K $2.2K $2.2K $2.2K $2.1K $159 $109 $119K $101K $91K
Retained Earnings -$104.4M -$84.97M -$115.6M -$116.0M -$111.6M -$107.4M -$103.9M -$100.0M -$95.96M -$89.14M
Accumulated Other Comp. Income -$21K -$24K -$24K -$23K -$16K -$20K -$22K -$14K -$4.7K $1.7K
Total Stockholders' Equity $33.29M $51.89M $27.65M $72.69M $89.92M $6.68M $5.09M $5.04M $5.77M $8.09M
Total Equity $33.29M $51.89M $27.65M $72.69M $89.92M $6.68M $5.09M $5.04M $5.77M $8.09M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-07-31 2026-04-30 2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-10-31
Cash & Cash Equivalents $17.74M $18.60M $20.17M $15.41M $13.18M $15.17M $16.38M $20.84M
Short-Term Investments $99K $254K $372K $201K $262K $366K $373K --
Cash & Short-Term Investments $17.84M $18.86M $20.54M $15.61M $13.44M $15.54M $16.76M $20.84M
Total Current Assets $30.97M $37.42M $20.70M $23.02M $19.11M $22.38M $16.96M $21.33M
Intangible Assets -- $0 $1.55M $1.55M $1.55M $1.55M $1.55M $1.55M
Other Non-Current Assets $7.7K $7.7K -- -- -- $7.7K -- --
Total Non-Current Assets $5.74M $9.33M $35.18M $32.95M $26.00M $32.79M $26.87M $33.77M
Total Assets $36.71M $46.75M $55.87M $55.98M $45.11M $55.17M $43.83M $55.10M
Accounts Payable $391K $271K $1.20M $1.02M $465K $399K $485K $349K
Total Current Liabilities $769K $826K $1.68M $1.58M $1.06M $2.91M $1.19M $4.78M
Total Non-Current Liabilities $6.13M $10.95M $14.79M $17.84M $458K $363K $2.38M $6.87M
Total Liabilities $6.90M $11.77M $16.47M $19.42M $1.52M $3.28M $3.58M $11.65M
Common Stock $2.6K $2.6K $2.6K $2.2K $2.2K $2.2K $2.2K $2.2K
Retained Earnings -$109.5M -$104.4M -$100.0M -$100.7M -$93.33M -$84.97M -$96.72M -$93.67M
Accumulated Other Comp. Income -$21K -$21K -$22K -$24K -$24K -$24K -$24K -$23K
Total Stockholders' Equity $27.51M $33.29M $38.11M $35.24M $43.59M $51.89M $40.25M $43.45M
Total Equity $27.51M $33.29M $38.11M $35.24M $43.59M $51.89M $40.25M $43.45M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30
Net Income -$19.42M $30.66M $334K -$4.32M -$4.24M -$3.55M -$3.83M -$4.07M -$6.83M -$4.44M
Stock-Based Compensation $892K $0 $675K $7.3K $33K $194K $369K $293K $580K $420K
Change in Payables -- -- -- -$243K $33K -$14K $64K -$231K -$13K $30K
Operating Cash Flow -$5.15M -$2.98M -$2.15M -$3.79M -$4.12M -$3.33M -$2.34M -$2.88M -$5.08M -$3.34M
Purchases of Investments -- -$7.00M $0 -- -- -- -- -- -- --
Investing Cash Flow $2.00M -$7.00M -$5.00M $0 $0 $0 $0 $0 $0 $0
Common Stock Issued -- -- -- $0 $87.36M $4.70M $2.66M $2.34M $2.68M $4.88M
Share Repurchases -$402K -$2.54M -$28.20M -$13.56M $0 -- -- -- -- --
Financing Cash Flow $6.58M -$25.03M -$10.71M -$13.56M $87.31M $4.64M $2.73M $2.34M $2.68M $4.88M
Net Change in Cash $3.43M -$35.01M -$17.86M -$17.36M $83.20M $1.31M $380K -- -- --

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-07-31 2026-04-30 2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-10-31
Net Income -$5.08M -$4.39M $747K -$7.42M -$8.36M $11.75M -$3.05M -$1.47M
Stock-Based Compensation -- $0 $772K $60K $60K $0 -$342K $119K
Operating Cash Flow -$781K -$1.39M -$787K -$980K -$1.99M -$1.04M -$510K -$1.05M
Purchases of Investments -- -- -- -$3.00M $0 $0 $0 $0
Investing Cash Flow -- $0 $5.00M -$3.00M $0 $0 $0 $0
Share Repurchases -- $0 -$402K $0 $0 -$172K -$225K -$1.40M
Financing Cash Flow -$83K -$170K $544K $6.21M $0 -$172K -$3.95M -$10.74M
Net Change in Cash -$865K -$1.56M $4.76M $2.23M -$1.99M -$1.21M -$4.46M -$11.80M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30 Apr 30
Return on Equity (ROE) -58.3% 59.1% 1.2% -5.9% -4.7% -53.2% -75.2% -80.7% -118.4% -54.9%
Return on Assets (ROA) -41.5% 55.6% 0.6% -5.9% -4.7% -48.0% -62.1% -70.3% -106.5% -51.3%
Current Ratio 45.28x 7.68x 6.80x 116.18x 121.38x 3.14x 1.01x 0.88x 1.99x 6.10x
Quick Ratio 22.82x 5.33x 6.76x 115.99x 121.24x 3.04x 0.87x 0.69x 1.65x 5.97x
Net Income Growth (YoY) -163.4% +9085.0% -- -- -- -- -- -- -- --
EPS Growth (YoY) -186.8% -- -- -- -- -- -- -- -- --
5Y Revenue / Share Growth -- -- -- -- -- -- -- -- -100.0% -100.0%
10Y Revenue / Share Growth -- -- -- -100.0% -100.0% -100.0% -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-07-31 2026-04-30 2026-01-31 2025-10-31 2025-07-31 2025-04-30 2025-01-31 2024-10-31
Return on Equity (ROE) -58.7% -58.3% -8.6% -20.1% -2.6% 59.1% 50.3% 52.2%
Return on Assets (ROA) -44.0% -41.5% -5.9% -12.6% -2.5% 55.6% 46.2% 41.2%
Current Ratio 40.30x 45.28x 12.33x 14.60x 18.01x 7.68x 14.20x 4.47x
Quick Ratio 23.21x 22.82x 12.24x 9.89x 12.67x 5.33x 14.03x 4.36x
Net Income Growth (YoY) -- -137.4% -- -- -135.7% +772.5% -- -152.7%
EPS Growth (YoY) -- -- -- -- -164.7% -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001157075) · from October 31, 2010 Data through July 31, 2026 · synced Nov 21, 2026, 05:09 UTC · Open in terminal